- Display 15 Products per page
The U.S Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications
Published: July 1, 2005 | Price: $3,000.00 – $6,000.00
This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace. In addition, the report provides a detailed analysis of consumer demographics and preferences in terms of...
The U.S. Market for Over-The-Counter Pain Medication
Published: January 1, 2005 | Price: $3,000.00 – $6,000.00
The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key issues, drivers, challenges, regulations and trends affecting the marketplace. The report provides a comprehensive analysis of the pain medication products that are currently in the...
U.S. Market for Over-the-Counter Gastrointestinal Products, 2nd Edition, The
Published: August 1, 2004 | Price: $1,995.00 – $5,990.00
The market for OTC Gastrointestinal products has gone through several significant changes in the past 5 years, most of which have to do with the Rx-to-OTC switches of two types of gastroesophageal reflux disease (GERD) drugs: H2 receptor antagonists and proton pump inhibitors (PPIs). This report on the U.S. market for OTC GI products presents a description of upper gastrointestinal conditions and diseases, the OTC treatments available, and clinical and business trends affecting the market, consumer behavior and attitudes, and...
Worldwide Market for Prescription Dermatological Drugs – 4th Edition, The
Published: February 1, 2004 | Price: $3,500.00 – $7,000.00
This report provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatologic Drugs is the fourth time Kalorama Information has comprehensively studied the dermatology markets. For this latest edition, Kalorama completely re-evaluated the market from the ground up, and in addition to the usual primary interviewing of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of...
OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition
Published: August 1, 2003 | Price: $1,496.00 – $2,992.00
The OTC women’s health market encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is driven by several factors including increasing number of baby boomers entering old age, increasing incidences of diseases; product demand; and several others. In response to many inquiries from readers of Kalorama Information’s March 2003 publication Women’s Health: Worldwide Prescription Drug Markets, 3rd Edition, we embarked on a supplemental study that goes beyond the prescription market to...
Market for Rx-to-OTC Switches, 3rd Edition, The
Published: May 1, 2003 | Price: $2,625.00 – $5,250.00
Switching dosages and ingredients of prescription medicines to the over-the-counter market is not new. In the past 30 years, more than 70 switches have produced hundreds of brands competing in the consumer market, and the pace promises to accelerate. Going OTC is one of a number of strategies marketers can use to extend the revenue life of their products. Appropriately coordinating the switch with patent expiry, creating coherent branding strategies, and knowing the clinical consumer climate are all factors in...